Table 1.
Demographic and clinical characteristics of cancer survivors (N=3,091)
| Characteristic | Total Sample n=3,091 |
Sexual Minority n=134 |
Heterosexual n=2,957 |
|---|---|---|---|
| Gender, n (%) | |||
| Male | 1,065 (34.5) | 57 (42.5) | 1,008 (34.1) |
| Female | 2,026 (65.1) | 77 (57.5) | 1,949 (65.9) |
| Race/Ethnicity, n (%) | |||
| Non-Hispanic White | 2,715 (87.8) | 117 (87.3) | 2,598 (87.9) |
| Hispanic and non-White | 376 (12.2) | 17 (12.7) | 307 (10.4) |
| Age, Mean (SE) | 48.85 (14.13) | 47.62 (11.78) | 48.90 (14.22) |
| Education, n (%) | |||
| High school or less | 266 (8.6) | 12 (9.0) | 254 (8.6) |
| Some college | 2,825 (91.4) | 122 (91.0) | 2,703 (86.8) |
| Employment Status, n (%) | |||
| Employed part/full time | 2,044 (66.1) | 89 (66.4) | 1,955 (66.1) |
| Unemployed/Retired | 1,047 (33.9) | 45 (33.6) | 1,002 (33.9) |
| Yearly Income, n (%) | |||
| $0–$80,000 | 1,832 (59.3) | 72 (53.7) | 1,770 (59.9) |
| $81,000–$121,000+ | 1,259 (40.7) | 62 (46.3) | 1,187 (40.1) |
| Common Cancers, n (%) | |||
| Breast | 745 (24.1) | 24 (17.9) | 721 (24.4) |
| Testicular | 254 (8.2) | 17 (12.7) | 237 (8.0) |
| Colorectal | 204 (6.6) | 9 (6.7) | 195 (6.6) |
| Prostate | 157 (5.1) | 8 (6.0) | 149 (5.0) |
| Lung | 63 (2.0) | 2 (1.5) | 61 (2.1) |
| Other | 1,668 (54.0) | 74 (55.2) | 1,594 (53.9) |
| Type of Treatment, n (%) | |||
| Chemotherapy | 1,935 (62.6) | 96 (71.6) | 1,839 (62.2) |
| Radiation | 1,474 (47.7) | 51 (38.1) | 1,423 (48.1) |
| Surgery | 2,280 (73.8) | 99 (73.9) | 2,181 (73.8) |
| Survivorship Time, n (%) | |||
| Less than 1 year | 675 (21.8) | 23 (17.2) | 652 (22.0) |
| 1 to 5 years | 1,159 (37.5) | 60 (44.8) | 1,099 (37.2) |
| More than five years | 906 (29.3) | 38 (28.4) | 868 (29.4) |
| Other/Unknown | 351 (11.4) | 13 (9.7) | 338 (11.4) |
| Sexual Orientation, n (%) | |||
| Heterosexual | 2,957 (95.7) | ||
| Lesbian/gay | 97 (3.1) | ||
| Bisexual | 37 (1.2) | ||